Evidence map›Paper›PMID 28973171›Full record

ArticleHuman molecular genetics2017

Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome.

Caterina Garone, Aaron R D'Souza, Cristina Dallabona, Tiziana Lodi, Pedro Rebelo-Guiomar, Joanna Rorbach, Maria Alice Donati, Elena Procopio, Martino Montomoli, Renzo Guerrini and 6 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. [Decreased plasma citrulline is a biochemical marker in newborn screening forZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. The role of m5C methyltransferases in cardiovascular diseases.Frontiers in cardiovascular medicine · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Genes · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Therapy Prospects for Mitochondrial DNA Maintenance Disorders.International journal of molecular sciences · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 4 countries.

Caterina GaroneMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, UK.
Aaron R D'SouzaMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, UK.
Cristina DallabonaDepartment of Chemistry, Life Sciences and Environmental Sustainability - University of Parma, Parma 43121, Italy.
Tiziana LodiDepartment of Chemistry, Life Sciences and Environmental Sustainability - University of Parma, Parma 43121, Italy.
Pedro Rebelo-GuiomarMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, UK.
Joanna RorbachMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, UK.
Maria Alice DonatiMetabolic Unit, A. Meyer Children's Hospital, Florence 50139, Italy.
Elena ProcopioMetabolic Unit, A. Meyer Children's Hospital, Florence 50139, Italy.
Martino MontomoliPediatric Neurology Unit and Laboratories, "A. Meyer" Children's Hospital, University of Florence, 50139, Italy.
Renzo GuerriniPediatric Neurology Unit and Laboratories, "A. Meyer" Children's Hospital, University of Florence, 50139, Italy.
Massimo ZevianiMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, UK.
Sarah E CalvoBroad Institute of MIT & Harvard, Cambridge, MA 02142, USA.
Vamsi K MoothaDepartment of Molecular Biology and Howard Hughes Medical Institute, Massachusetts General Hospital, and Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Salvatore DiMauroDepartment of Neurology, Columbia University Medical Center, New York, NY 10032, USA.
Ileana FerreroDepartment of Chemistry, Life Sciences and Environmental Sustainability - University of Parma, Parma 43121, Italy.
Michal MinczukMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, UK.
Meyer Children's Hospital · ITMedical Research Council · GBUniversity of Parma · ITMRC Mitochondrial Biology Unit · GBColumbia University Irving Medical Center · USHarvard University · USHoward Hughes Medical Institute · USUniversity of Cambridge · GB

Funding

Characterization of the Mitochondrial ProteomeR01GM077465 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MOOTHA, VAMSI KRISHNA · 2007 to 2016
$4.3M
Mitochondrial Parts, Pathways, and PathogenesisR35GM122455 · NIGMS · BROAD INSTITUTE, INC. · PI MOOTHA, VAMSI KRISHNA · 2017 to 2021
$4.0M
Medical Research Council MC_U105697135Medical Research Council MC_UP_1002/1Medical Research Council MC_UU_00015/4Medical Research Council MC_UU_00015/5Medical Research Council MC_UU_00015/7Medical Research Council MC_UU_00015/8NIGMS NIH HHS R01 GM077465NIGMS NIH HHS R35 GM122455
6 · The paper itself

Abstract

Defects in nuclear-encoded proteins of the mitochondrial translation machinery cause early-onset and tissue-specific deficiency of one or more OXPHOS complexes. Here, we report a 7-year-old Italian boy with childhood-onset rapidly progressive encephalomyopathy and stroke-like episodes. Multiple OXPHOS defects and decreased mtDNA copy number (40%) were detected in muscle homogenate. Clinical features combined with low level of plasma citrulline were highly suggestive of mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome, however, the common m.3243 A > G mutation was excluded. Targeted exome sequencing of genes encoding the mitochondrial proteome identified a damaging mutation, c.567 G > A, affecting a highly conserved amino acid residue (p.Gly189Arg) of the MRM2 protein. MRM2 has never before been linked to a human disease and encodes an enzyme responsible for 2'-O-methyl modification at position U1369 in the human mitochondrial 16S rRNA. We generated a knockout yeast model for the orthologous gene that showed a defect in respiration and the reduction of the 2'-O-methyl modification at the equivalent position (U2791) in the yeast mitochondrial 21S rRNA. Complementation with the mrm2 allele carrying the equivalent yeast mutation failed to rescue the respiratory phenotype, which was instead completely rescued by expressing the wild-type allele. Our findings establish that defective MRM2 causes a MELAS-like phenotype, and suggests the genetic screening of the MRM2 gene in patients with a m.3243 A > G negative MELAS-like presentation.

Indexed as

Amino Acid SequenceChildDNA, MitochondrialHumansMaleMELAS SyndromeMethyltransferasesMitochondriaMitochondrial EncephalomyopathiesMutationNuclear ProteinsRNA, RibosomalRNA, Ribosomal, 16SSaccharomyces cerevisiae21S rRNADNA, MitochondrialMethyltransferasesMRM2 protein, humanNuclear ProteinsRNA, RibosomalRNA, Ribosomal, 16SrRNA (adenosine-O-2'-)methyltransferase

Identifiers

PMID28973171
PMCPMC5886288
OpenAlexW2747565683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.